Dimension Therapeutics, Inc. — Form D/A
Dimension Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2015-02-11. The offering totals $24.5M, of which $24.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2015-02-11
- Form: D/A
- Accession: 0001592288-15-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $24.5M
- Amount sold: $24.5M
- Investors: 2
- Date of first sale: 2013-10-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-206529
Issuer
- Name: Dimension Therapeutics, Inc.
- CIK: 0001592288
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 840 Memorial Drive, 4th Floor, Cambridge, MA, 02139
- Phone: 617-401-0011
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Benjamin J Auspitz | Director | Cambridge, MA |
| Allan J Fox | Director | Cambridge, MA |
| Donald J Hayden | Director | Cranbury, NJ |
| Rishi Gupta | Director | New York, NY |
| Annalisa Jenkins | Director | Dallas, TX |
| Annalisa Jenkins | Executive Officer | Dallas, TX |
| Donald J Hayden, Jr. | Director | Philadelphia, PA |
| Thomas Beck | Director | Milwaukee, WI |
| Thomas Beck | Executive Officer | Milwaukee, WI |
| Benjamin Auspitz | Director | Skillman, NJ |
| Jay K Hachigian | Executive Officer | Boston, MA |
| Donald Hayden | Director | Cambridge, MA |
Other filings by this issuer (2)
More